Kazuki Matsui

Kazuki Matsui

Auto-generated profile, based on publicly available information

Kazuki Matsui

Biopharmaceutics Group, Pharmaceutical R&D, Ono Pharmaceutical Co., Ltd., Japan

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2011 in Cardiovascular Research
Verified
Journal Article
Open access
PDF file
TYTomomi Yamashita
Tomomi Yamashita
TITomohiko Iwakura
Tomohiko Iwakura
KMKazuki Matsui
Kazuki Matsui
HKHaruyo Kawaguchi
Haruyo Kawaguchi
MOMasanori Obana
Masanori Obana
YFYasushi Fujio
Yasushi Fujio
Interleukin (IL)-17-producing helper T (Th17) cells have been proposed to participate in the pathogenesis of chronic inflammation, such as autoimmune myocarditis. IL-6 gene ablation confers the resistance to experimental autoimmune myocarditis (EAM). In this study, we have addressed the pathological roles of IL-6 in the regulation of Th17 cells in EAM. To induce EAM, mice were immunized twice with α-myosin heavy chain peptide. Three weeks after the first injection, the cardiac expression of the Th17-specific transcription factor, retinoic acid receptor-related orphan nuclear receptor (ROR γt), was up-regulated. Consistently, Th17 cells were recruited into EAM hearts, as analysed by flow cytometry. Using the mice with enhanced green fluorescence protein (eGFP) gene knocked-in at RORγt locus (RORγt-eGFP mice), we observed Th17 cell infiltration into inflamed lesions. Pre-treatment with IL-6 receptor (IL-6R)-blocking antibody (anti-IL-6R Ab) inhibited EAM induction in terms of disease severity score (3.5 ± 0.8; IgG vs. 0.5 ± 0.8; anti-IL-6R Ab, n = 6, P< 0.01) and suppressed the myocardial expression of IL-17 and RORγt. In contrast, the administration of anti-IL-6R Ab 7 days after the first immunization failed to show the inhibitory effects, suggesting that IL-6 plays important roles in EAM initiation. Finally, by generating RORγt-eGFP homozygous mice, we revealed that RORγt gene ablation conferred the resistance to EAM induction. IL-6-mediated induction of Th17 cells is critical for the onset of EAM, but not for its progression. IL-6/Th17 signalling could be a promising therapeutic target for the prevention of myocardial inflammation.

1 August 2015 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
YTYasuhiro Tsume
Yasuhiro Tsume
STSusumu Takeuchi
Susumu Takeuchi
KMKazuki Matsui
Kazuki Matsui
GAGregory E. Amidon
Gregory E. Amidon
GAGordon L. Amidon
Gordon L. Amidon

1 May 2017 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
YTYasuhiro Tsume
Yasuhiro Tsume
KMKazuki Matsui
Kazuki Matsui
ASAmanda L. Searls
Amanda L. Searls
STSusumu Takeuchi
Susumu Takeuchi
GAGregory E. Amidon
Gregory E. Amidon
GAGordon L. Amidon
Gordon L. Amidon

27 May 2015 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
KMKazuki Matsui
Kazuki Matsui
YTYasuhiro Tsume
Yasuhiro Tsume
GAGregory E. Amidon
Gregory E. Amidon
GAGordon L. Amidon
Gordon L. Amidon

1 March 2018 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
Bart HensBart Hens
Bart Hens
Marival BermejoMarival Bermejo
Marival Bermejo
YTYasuhiro Tsume
Yasuhiro Tsume
IGIsabel Gonzalez-Alvarez
Isabel Gonzalez-Alvarez
HRHao Ruan
Hao Ruan
GAGordon L. Amidon
Gordon L. Amidon

1 September 2016 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
KMKazuki Matsui
Kazuki Matsui
YTYasuhiro Tsume
Yasuhiro Tsume
GAGregory E. Amidon
Gregory E. Amidon
GAGordon L. Amidon
Gordon L. Amidon